Bonacci R, Pinchera A, Fierabracci P, Gigliotti A, Grasso L, Giani C
Istituto di Endocrinologia, University of Pisa, Italy.
J Endocrinol Invest. 1996 Mar;19(3):159-64. doi: 10.1007/BF03349859.
Several authors have demonstrated the presence of estrogen receptors (ER) and progesterone receptors (PR) in thyroid tissue, generally using dextran coated charcoal method (DCCA). The aim of the study was to measure ER and PR in thyroid specimens using an immunoenzymatic method, and to evaluate the meaning of different prevalence of ER and PR in malignant and benign thyroid disease, as compared with normal thyroid tissue. We have measured ER and PR in thyroid tissue from 28 benign and 20 malignant thyroid lesions, and in 38 samples of surrounding normal thyroid tissues. The sensitivity of ER-EIA and PR-EIA was 1.0 and 1.5 fmol/mg protein, respectively. In thyroid carcinoma the frequency of ER positivity (ER+) was 7/20 (35%); it was significantly higher in the surrounding normal tissue (15/20; 71%) (p = 0.03). In benign thyroid disease, the prevalence of ER+ was 11/28 (39%) and in the surrounding normal tissue it was 11/18 (61%) (p = not significant). PR+ was detected in 7/20 (35%) thyroid cancers and in 15/28 (53%) benign lesions without significant difference with the frequency detected in the surrounding normal tissues. ER and PR concentrations (mean +/- SD) in thyroid cancer was 2.2 +/- 2.2 and 2.2 +/- 2.9 respectively, similarly to that detected in benign thyroid disease and in normal tissue. The simultaneous presence of ER and PR (ER+PR+) was also evaluated. We have found that the frequency of ER+ PR+ was significantly higher in benign lesions (8/28; 28.6%) as compared with malignant samples (1/20; 5%) (p < 0.05); the frequency of ER+PR+ was significantly higher in normal tissue surrounding the malignant lesions (9/20; 45) (p = 0.003). Our data indicate i) EIA method is appropriate to detect ER and PR in thyroid tissue. ii) The frequency of ER+ and ER+PR+ specimens is significantly higher in normal thyroid tissue than in pathologic tissues. This indicates that ER and PR immunoassays may be useful tools to evaluate the normal biological activity of thyroid cells.
几位作者已证实甲状腺组织中存在雌激素受体(ER)和孕激素受体(PR),一般采用葡聚糖包被活性炭法(DCCA)。本研究的目的是使用免疫酶法测定甲状腺标本中的ER和PR,并评估与正常甲状腺组织相比,ER和PR在恶性和良性甲状腺疾病中不同患病率的意义。我们测定了28例良性和20例恶性甲状腺病变的甲状腺组织以及38例周围正常甲状腺组织样本中的ER和PR。ER - EIA和PR - EIA的灵敏度分别为1.0和1.5 fmol/mg蛋白质。在甲状腺癌中,ER阳性(ER +)的频率为7/20(35%);在周围正常组织中显著更高(15/20;71%)(p = 0.03)。在良性甲状腺疾病中,ER +的患病率为11/28(39%),在周围正常组织中为11/18(61%)(p = 无显著性差异)。在7/20(35%)的甲状腺癌和15/28(53%)的良性病变中检测到PR +,与在周围正常组织中检测到的频率无显著差异。甲状腺癌中ER和PR的浓度(平均值±标准差)分别为2.2±2.2和2.2±2.9,与在良性甲状腺疾病和正常组织中检测到的浓度相似。还评估了ER和PR的同时存在(ER + PR +)情况。我们发现,与恶性样本(1/20;5%)相比,良性病变中ER + PR +的频率显著更高(8/28;28.6%)(p < 0.05);恶性病变周围正常组织中ER + PR +的频率显著更高(9/20;45%)(p = 0.003)。我们的数据表明:i)EIA方法适用于检测甲状腺组织中的ER和PR。ii)正常甲状腺组织中ER +和ER + PR +标本的频率显著高于病理组织。这表明ER和PR免疫测定可能是评估甲状腺细胞正常生物学活性的有用工具。